The U.S. virtual care market size was USD 2.26 billion in 2023, calculated at USD 2.99 billion in 2024 and is projected to surpass around USD 49.68 billion by 2034, expanding at a CAGR of 32.5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Virtual Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Virtual Care Market, by Application, 2024-2034
8.1.1. Family Medicine
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Internal Medicine
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cardiology
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Paediatrics
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Endocrinology
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Rheumatology
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Pulmonology
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)
9.1. US Virtual Care Market, by Consultation Mode, 2024-2034
9.1.1. Audio
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Video
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Messaging
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. US
10.1.1. Market Revenue and Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Forecast, by Consultation Mode (2021-2034)
11.1. AMD Global Telemedicine
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. CHI Health
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. ATandT
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Koninklijke Philips N.V.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. GENERAL ELECTRIC COMPANY
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cerner Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MDLIVE Inc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens Healthcare GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. United HealthCare Services, Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. American Well
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample